why choose us

First received: December 11, 2022

Clinical Trial: Orexin Receptor Antagonists as Modulators of Threat Sensitivity in Individuals With Alcohol Use Disorder

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Alcohol Use Disorder

Study Type: INTERVENTIONAL


Official Title: Orexin Receptor Antagonists as Modulators of Threat Sensitivity in Individuals With Alcohol Use Disorder

Brief Summary: The goal of this double-blind clinical trial is to further explore if, how, and for whom orexin antagonism modifies brain-behavior stress targets in moderate to severe alcohol use disorder (AUD).The main questions it aims to answer are:Does an acute dose of suvorexant (SUV) and/or daily use of SUV modify brain-behavior targets of AUD dysfunction?Does daily SUV use change alcohol behavior and if so, is this change in behavior linked to brain-behavior change?Participants will be randomized to a treatment group…

Read more